Introduction
Fulminant septicaemia is now a well recognized consequence of splenectomy or hyposplenic states. Although the syndrome was originally described in children in the two years after splenectomy1 it is now commonly recognized in adults, sometimes 30 years or more after splenectomy2.
The characteristic pattern of post-splenectomy sepsis (PSS) is that of a rapidly progressive febrile illness, without focal physical signs and with a mortality of 50% despite treatment. Streptococcus pneumoniae is the usual causative organism. In some patients a meningitic syndrome dominates the clinical picture, usually as a fulminant illness but sometimes with a more prolonged and less dramatic course3. Whilst S. pneumoniae is also the commonest infecting organism in these meningitic syndromes, Neisseria meningitidis4 and Haemophilus influenzae5 have been incriminated.
Patients and clinical reports The 6 episodes of bacterial meningitis occurred in 5 splenectomised Nottingham patients during the period January 1974 to December 1985. Two patients died. In all cases the infecting organism was S. pneumoniae, cultured from cerebrospinal fluid (CSF).
During the same period a-total of 435 cases of bacterial meningitis (mean 36 cases per year) were admitted to the Nottingham hospitals serving a population of 0.6 million. Sixty-nine (16%) were due to S. pneumoniae (Ispahani, personal communication). The hospitals had performed 448 emergency and elective splenectomies during the same period.
The main features of the cases are summarized in Table 1 . Case 1: When aged 8 years she was involved in a road traffic accident. At a subsequent laparotomy for extensive intra-abdominal trauma she underwent splenectomy.
Six years later she developed a headache with fever and neck stiffness over a 4-day period and was admitted to hospital. Examination suggested acute meningitis and subsequent culture of turbid CSF and blood grew S. pneumoniae. She received intravenous, and at the time of the initial lumbar puncture intrathecal, penicillin and made a complete recovery over the next 10 days.
Two years later she was admitted again after being unwell for 5 days latterly with headache and vomiting. She clinically had meningitis and after demonstration ofpurulent CSF she was treated with penicillin. Her CSF subsequently grew S. pneumoniae although blood cultures were not performed. She recovered quickly and was discharged after 7 days.
She had not received any prophylaxis with pneumococcal vaccine and had not taken prophylactic oral penicillin. 2: This 43-year-old man had a staging laparotomy and splenectomy for Hodgkin's disease in 1975. He received no prophylactic vaccination nor penicillin. He was found to have stage IhIB disease and was treated by chemotherapy using a MOPP regimen (mustine, Oncovin, procarbazine and prednisolone). Twelve months after finishing his treatment he became unwell over a 2-day period with a fever, rigors, headache and confusion. When admitted to hospital he was comatose and toxic with signs of meningitis.
Examination of his CSF demonstrated gram positive diplococci with absent sugar and an elevated protein at 2.8 g/l. Streptococcus pneumoniae type 7 was subsequently isolated from blood and CSF samples.
He received high dose intravenous penicillin and made a full recovery. Case 3: When 10 years old, this boy fell 30 ft from scaffolding. He was admitted in a shocked state with abdominal pain and underwent laparotomy when a ruptured spleen was excised. He received no pneumococcal vaccine nor penicillin.
Nine years later he developed a sore throat and within hours suffered a rigor and was admitted to hospital. He received parenteral penicillin. Unfortunately he suffered a cardiorespiratory arrest 20 hours after the first rigor from which resuscitation was unsuccessful.
At postmortem small nodules of residual splenic tissue were demonstrated in the splenic bed, under the diaphragm and around the liver. Streptococcus pneumoniae type 1 was cultured from blood, brain and lung. There was no evidence of previous skull fracture.
Case 4: A 66-year-old woman presented with malaise and massive splenomegaly. There were no other abnormalities on examination nor investigation and she underwent a diagnostic splenectomy. The spleen was histologically involved by non-Hodgkin's lymphoma but there was no evidence of disease elsewhere. She received no pneumococcal vaccine nor prophylactic penicillin, nor any adjuvant chemotherapy. She remained well for 3% years but then relapsed with generalized lymphadenopathy, hepatomegaly and bone marrow infiltration. She underwent 6 courses of chemotherapy using the COP regimen (cyclophosphamide, Oncovin and prednisolone). However, shortly after completing this course of treatment she was readmitted with fever, signs of lobar pneumonia and meningitis. Examination ofturbid CSF revealed absent glucose and gram-positive diplococci. She was treated with benzyl penicillin and required sedation for status epilepticus. Her condition deteriorated and she died 5 days after onset of illness. Antemortem cultures of blood and CSF grew S. pneumoniae type 6. At postmortem there was no macroscopic evidence of lymphoma.
Case 5: (previously reported6) A 56-year-old woman with warm antibody autoimmune haemolytic anaemia developed unacceptable side effects after 7 months of therapy with prednisolone; despite achieving good haemoglobin levels. On stopping steroid therapy her haemoglobin fell and she underwent an elective splenectomy after further steroid therapy in February 1983, having received pneumococcal (14 valent) vaccine 11 days previously. Her haemoglobin subsequently rose and remained at satisfactory levels.
In November 1985, following an upper respiratory tract infection, within hours she developed a headache with confusion. She was admitted to hospital with signs of meningitis and a left hemipares;is. Following a normal CT brain scan, CSF examination revealed gram-positive diplococci with an absent CSF glucose. Both blood and CSF subsequently grew S. pneumoniae type 10. Despite prompt treatment with high dose penicillin, her illness ran a protracted course with status epilepticus and cortical vein thrombophlebitis. After 5 weeks hospitalization, she was discharged with residual left sided weakness, vertigo and diplopia which has persisted.
Discussion
The clinical syndrome of overwhelming fulminant infections, usually pneumococcal, in asplenic patients is now well recognized. However, other postsplenectomy syndromes of infection are emerging of which bacterial meningitis is but one. Some patients may acquire chronic infections such as pneumococcal endocarditis7 or salmonellosis8. Furthermore, splenectomized or asplenic individuals are vulnerable to infection with a variety of other organisms. These include malaria9, histoplasmosis'0, babesiosis2 and perhaps even disseminated Herpes varicella-zoster". Multiply transfused splenectomized patients may also be especially vulnerable to cytomegalovirus infections'2.
As in the present series, the commonest organism causing acute meningitis in the asplenic or hyposplenic host is the pneumococcus13. However, N. meningitidis4 and H. influenzae5, both encapsulated bacteria, are incriminated in being responsible for an increased number of infections in this 'at risk' population. As well as splenectomized patients, those with impaired splenic function as with homozygous sickle cell disease may develop meningitis'4.
From our own experience in Nottingham we can determine crude risks of infection from this unselected group of patients presenting to the local hospitals. Our six episodes of bacterial meningitis occurred during the same 12 years that 448 splenectomies were performed. Thus we encountered one case of bacterial meningitis for every 75 operations. This compares with an overall rate for bacterial infections of one septicaemic episode for every 16 operations reported by us in another study -from 1980 to 19856.
A comparison with normal healthy individuals is difficult. The remaining 63 episodes of pneumococcal meningitis in the 600 000 population represents crudely one case for every 10 000 individuals over the 12 years. Thus the splenectomised population has a hundred fold increased risk compared with the healthy population.
It is interesting that 3 out of our 5 patients developed meningitis several years after splenectomy. Most cases of PSS occur within 2 years of splenectomy, although cases are now being described up to 20 years afterwards'5"16. The role of immunization with pneumococcal vaccines is questionable. Only one patient in our series received pneumococcal vaccine;
she recovered from an infecting pneumococcus whose capsular type is not included in the current Pneumovax preparation. The two unvaccinated patients who died both suffered infections from pneumococcal capsular types included in this vaccine which only became available just before their fatal illnesses. There is still no good evidence that pneumococcal vaccines protect or reduce the number of episodes of pneumococcal disease after splenectomy and high risk patients in general seem unable to mount adequate immunological responses to the vaccine17. Nevertheless even limited protection against PSS in some hyposplenic patients must be beneficial and a general policy for using the current 23-valent pneumococcal vaccine should be encouraged. Certainly vaccination should be performed before elective splenectomy. Here a period of at least two weeks is recommended to maximize the immunological response to the vaccine16'18.
Prophylactic penicillin is unquestionably effective in preventing pneumococcal infection but long-term compliance is unlikely in most patients19 and would not prevent Haemophilus infections.
One alternative would be a 'first aid' supply of a course of penicillin for patients to take immediately they become febrile. This would be significantly less effective against infecting Haemophilus and in areas where penicillin-resistant pneumococci or meningococci are clinically important.
A meningococcal group A & C vaccine is effective in individuals with normal splenic function. It has been used with limited success in individuals with impaired splenic function. Antibody responses were similar to normal in groups of patients previously splenectomized for trauma but poor in asplenic individuals with malignancy4. Rates of infection were not examined. As the risk of meningococcal infection is higher in these patients than in normal individuals, it may well be worth vaccinating them with a meningococcal vaccine. Consideration should certainly be given to traumatically and electively splenectomized individuals where the higher antibody response to the vaccine would make vaccination clinically more useful. No effective group B meningococcal vaccine is yet available. Long-term chemoprophylaxis against meningococcaemia is more difficult than with the pneumococcus because ofthe ineffectiveness ofpenicillin in clearing nasopharyngeal carriage, increasing sulphonamide resistance and rapidly acquired resistance against rifampicin.
A vaccine against Haemophilus influenzae type b has not yet been recommended for use in asplenic individuals20. It is effective in normal children over 2 years of age, but its efficacy has not been studied in asplenic children or adults. In parallel with the other vaccines considered here it is likely to be less effective in such patients. With such limited experience it is difficult to advocate its use. This particular vaccine is much less effective in normal children under 2 years of age when they are most at risk of such Haemophilus infections. Interestingly the vaccine's immunogenicity in such infants has been increased by conjugation with diphtheria toxoid2l.
The immunological role of splenic nodules (splenosis) as in case 3 is questionable. There have been suggestions that after splenectomy for trauma, where the spleen had been shattered within the peritoneal cavity, there is more likelihood of splenosis developing than after clean elective splenectomy. A protective role of splenosis against PSS was suggested by Pearson and workers22 who found lower rates of infection after trauma than after other forms of splenectomy. Elegant studies by Gorazza et aL23 have confirmed the presence of splenosis after traumatic splenectomy; these nodules seem to regain the 'pitting' function of the previously excised spleen. This does not of course imply complete restoration of immunological function and Rice and James24 pointed out that ectopic splenic tissue failed to prevent PSS.
With the unproven value of these vaccines and the difficulty of compliance with long-term penicillin prophylaxis, what should the clinician looking after splenectomized individuals do to reduce their risk of infection? We offer the following pragmatic but personal advice:
(1) Give the current polyvalent pneumoccal vaccine at least 2 weeks before elective surgery, and to all other asplenic individuals thus giving them the benefit over any doubts of efficacy.
(2) Consider meningococcal vaccination before elective surgery and after splenectomy for trauma. (3) Attempt to give daily prophylactic penicillin, at least for the first two years after splenectomy when the risk of pneumococcal sepsis is highest. This applies particularly to children. (4) Provide all asplenic patients with high dose amoxycillin sachets (or high dose -'Augmentin' for increased Haemophilus cover) to keep at home and to start taking immediately they become feverish, even if only with a cold. (5) Warn all splenectomized patients of the risk of rapidly developing infections and of the need for prompt medical attention.
